论文部分内容阅读
目的:探究冬虫夏草制剂联用贝那普利治疗早期糖尿病肾病的临床效果。方法:将本院收治的158例早期糖尿病患者随机分为实验组和对照组,两组均对高血糖、高血压进行控制,对照组采用贝那普利治疗,实验组采用贝那普利联合百令胶囊治疗。结果:实验组患者的功能评价指标UAE、UAER、SCr、BUN等下降水平明显优于对照组(P<0.05);实验组患者疗效评价均优于对照组(P<0.05)。结论:对早期糖尿病肾病患者采用冬虫夏草制剂联用贝那普利治疗可以明显增强治疗效果,改善患者的生活质量。
Objective: To investigate the clinical efficacy of Cordyceps sinensis combined with benazepril in the treatment of early diabetic nephropathy. Methods: One hundred and eighty-eight patients with early-stage diabetes admitted to our hospital were randomly divided into experimental group and control group. Both groups were controlled by hyperglycemia and hypertension. The control group was treated with benazepril. The experimental group was treated with benazepril Bailing capsule treatment. Results: The decline of UAE, UAER, SCr and BUN in the experimental group was significantly better than that in the control group (P <0.05). The curative effect of the experimental group was better than that of the control group (P <0.05). Conclusion: The treatment of early diabetic nephropathy with Cordyceps sinensis plus benazepril treatment can significantly enhance the therapeutic effect and improve the quality of life of patients.